Ignite Creation Date:
2025-12-24 @ 5:12 PM
Ignite Modification Date:
2025-12-24 @ 5:12 PM
Study NCT ID:
NCT04103450
Status:
COMPLETED
Last Update Posted:
2024-08-21
First Post:
2019-09-23
Is Possible Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Extension Study of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia
Sponsor:
Urovant Sciences GmbH
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
URO-901-3006
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None